When Should You Start KOL Engagement?

Most pharmaceutical companies start engaging KOLs during Phase 3 clinical trials. In our newest blog we look at why this makes sense and also discuss situations when bringing KOLs on board earlier during drug development might be the way to go.

Read more

Meet Monocl - Dan Chupka, Sales Director

At Monocl, we take pride in our remarkable team of kind and talented individuals who continue to make a positive impact on a daily basis. Meet Monocl's own DJ and Newscaster – Dan Chupka!

Read more

Meet Monocl - Rebecka Strandberg, Sales Development Representative

“The greatest sense of belonging” - Five Words that sum up Rebecka’s experience at Monocl. Find out what else Rebecka loves about working at Monocl.

Read more

The opinion leaders and rising stars in HER2-positive Breast Cancer

Your weekly stakeholder digest, this week with leading experts in HER2-positive breast cancer. In this post we outline the opinion leaders, rising stars and other key stakeholders as well as investigator and clinical trials trends.

Read more

Life Science Marketing - Beyond Conference Booths and Trade Journal Ads

Life science marketers tend to err on the side of caution. The hottest new trends? Can everybody else please go first, we’ll join you later! While this makes sense in our industry, the time for whole-heartedly embracing content-driven email marketing campaigns is now. Actually, it was yesterday, but today will do. Get an overview by reading our blog.

Read more

Meet Monocl - Kristoffer Gustafsson, Head of Product

Kristoffer has been with us since the beginning and has been a vital team member throughout our journey. Check out what Kristoffer has to say about his experience at Monocl!

Read more